On June 14, 2022, the 6th Future Medical Top 100 Conference hosted by VBData was grandly opened online. On the evening of the 15th, the Future Medical Top 100· Cloud Award Ceremony was held, and the 2022 future medical top 100 list was heavily announced with great attention from the industry. ArteryFlow was once again on the list, winning "2022 Future Medical Top 100 · Innovative Medical Devices Top 100" and "Future Medical Top 100 · Pengcheng Award · Annual Innovative Enterprise Award". This is the third time that ArteryFlow Technology has been listed in the future medical top 100 list, which fully reflects the industry's recognition of ArteryFlow's strength and growth potential.

 

Among them, the list of the Future Medical Top 100 mainly takes the latest post-investment valuation of enterprises as the core assessment index and integrates human resources, knowledge resources, important partner resources, market performance and other indicators. Through institutional recommendation, cross review, expert review and other processes, it aims to select Chinese innovative medical practitioners who truly represent the future medical industry and discover the core strength of China's future medical industry. The "Pengcheng Award" implies a bright future. It is a symbol of prosperity, strength, wisdom and vitality, and represents the demeanor of enterprises in the medical and health field who are struggling and innovate.

 

This award fully reflects the industry's recognition will still adhere to the concept of "making medical treatment more precise", with a more open attitude, through diversified cooperation methods, gathering industry resources, and leading the development of intelligent diagnosis and treatment of cardiovascular and cerebrovascular diseases with more ecological partners, provide a more comprehensive, high-quality and precise diagnosis and treatment services, and help the construction of China's precision medical system.